Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter
Brand(s)
Last updated
Summary
Product
Dantrium Intravenous (Dantrolene sodium for injection)
Issue
Health products - Contamination
What to do
Consult your healthcare provider for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Knight Therapeutics Inc. |
Dantrium Intravenous (Dantrolene sodium for injection) |
DIN 01997572 |
Powder For Solution |
20 mg/vial |
80681 |
Issue
Presence of particulate matter in affected lots.
What you should do
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Knight Therapeutics Inc.
100 boul. Alexis-Nihon, suite 600,
Montreal, QC, H4M 2P2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-82808
Get notified
Receive emails about new and updated recall and safety alerts.